Patent · US Active

Fc receptor binding proteins

US8273351B2 · kind B2 · utility

18Cited by

4References

6Claims

0Family size

Assignees

Dyax Corp. · US
Syntonix Pharmaceuticals, Inc. · US

Inventors

Christopher TenHoor · Hopkinton, US
Arumugam Muruganandam · Bengaluru, IN
Robert Charles Ladner · Urbana, US
Clive Wood · Boston, US
Alan J. Bitonti · Acton, US
James Stattel · Hagerstown, US
Kevin McDonnell · Lexington, US
Liming Liu · Whitemarsh, US
Jennifer A. Dumont · Groton, US
Aaron Sato · Somerville, US

Key dates

Filing date	Apr 24, 2009
Grant date	Sep 25, 2012
Priority date	—
Expiry date	Nov 30, 2029

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/70535
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.